Cellerant Therapeutics Secures $2,190,000 New Financing

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c74d6686-26f1-45dd-b875-6cb6d5a36e78
Date
1/23/2014
Company Name
Cellerant Therapeutics
Mailing Address
1561 Industrial Road San Carlos, CA 94070
Company Description
Cellerant Therapeutics Inc. is a clinical-stage biotechnology company developing and commercializing the use of hematopoietic (blood-forming) stem cell-based therapies for the treatment of a variety of cancers and autoimmune diseases.
Website
http://www.cellerant.com
Transaction Type
Debt
Transaction Amount
$2,190,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Includes conversion of $1,144,342 of previous indebtedness. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor
Undisclosed